TransCure bioServices
TransCure offers pre-clinical contract research services to pharmaceutical, biotech, start-up and academic researchers who need faster, smarter and more cost-effective solutions for drug profiling. Uniquely designed animal models with functional humanized systems have been developed to provide predictive in vivo pharmacology testing in the fields of inflammation and autoimmune diseases (IBD, RA, SLE, MS), infectious diseases (HIV, HBV), vaccine development and biosimilar and preclinical lead candidate selection/validation for drug development.
Latest TransCure bioServices Content
Webinar
Humanized Models for More Accurate Infectious Disease Research
On-Demand
This webinar explores how the latest humanized mouse models are advancing infectious disease research by helping scientists evaluate drug candidates of interest.
Webinar
Humanized Models for Inflammatory Disease and Allergy Research
On-Demand
This webinar explores how the latest humanized mouse models are advancing inflammatory disease research by helping scientists evaluate drug candidates of interest.
Webinar
Humanized Models for Greater Immuno-Oncology Preclinical Accuracy
On-Demand
This webinar explores how the latest humanized mouse models are advancing immuno-oncology by helping researchers study immune checkpoint blockades.
eBook
Unlock the Potential of Your Preclinical Oncology Studies
This eBook explores how humanized mouse models can accelerate the development of novel, safe, and effective oncology treatment
Product News
TransCure bioServices Delivers CDX Mouse Models To Advance AML Preclinical Studies
TransCure bioServices has developed cell line-derived xenograft mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukemia.
Article
Advanced Oncology Treatment Candidates Developed With Next-Generation Preclinical Models
In this article, we explore the role of preclinical models in oncology drug discovery and how the right model can help to accelerate the development of the most promising treatments.
Product News
TransCure bioServices Offers BioVolume 3D Imaging
The new service is a world first in 3D imaging, allowing the measurement and visualization of tumor growth in animal models across preclinical research, oncology and drug development.
Advertisement
